Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors

Carcinogenesis

Volumn 23, Issue 8, 2002, Pages 1387-1397

  Wei, Min ^a   Wanibuchi, Hideki ^a   Morimura, Keiichirou ^a   Iwai, Shuji ^a   Yoshida, Kaoru ^a   Endo, Ginji ^a   Nakae, Dai ^b   Fukushima, Shoji ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ARSENIC DERIVATIVE; ARSENOBETAINE; ARSONIC ACID DERIVATIVE; BETA CATENIN; BROXURIDINE; CACODYLIC ACID; CYCLIN D1; CYCLOOXYGENASE 2; DRINKING WATER; ORGANOARSENIC DERIVATIVE; PROTEIN P53; RAS PROTEIN; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; BLADDER CARCINOGENESIS; BLADDER EPITHELIUM; BLADDER PAPILLOMA; CANCER RISK; CARCINOGENICITY; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; MUTATIONAL ANALYSIS; NODULAR HYPERPLASIA; NONHUMAN; ONCOGENE H RAS; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; RAT; TRANSITIONAL CELL CARCINOMA; URINE LEVEL; WATER CONTAMINATION;

EID: 0036053457     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/23.8.1387     Document Type: Article

References (71)

1. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Some Metals and Metallic Compounds
2. Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans
3. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water
4. Cancer risks from arsenic in drinking water
5. The enigma of arsenic carcinogenesis: Role of metabolism
6. Experimental study on carcinogenicity of beryllium oxide and arsenic trioxide to the lung of rats by an intratracheal instillation (author's transl)
7. Carcinomas of the respiratory tract in hamsters given arsenic trioxide and/or benzo[a]pyrene by the pulmonary route
8. Is the human carcinogen arsenic carcinogenic to laboratory animals?
9. Biotransformation and intracellular binding of arsenic in tissues of rabbits after intraperitoneal administration of 74As labelled arsenite
10. Comparison of several methods for the determination of arsenic compounds in water and in urine. Their application for the study of arsenic metabolism and for the monitoring of workers exposed to arsenic
11. Metabolism of inorganic arsenic (74As) in humans following oral ingestion
12. Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats
13. Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens
14. Promotion of rat hepatocarcinogenesis by dimethylarsinic acid: Association with elevated ornithine decarboxylase activity and formation of 8-hydroxy-deoxyguanosine in the liver
15. Promoting effects of dimenthylarsinic acid on N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in rats
16. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats
17. Chronic carcinogenicity assessment of cacodylic acid
18. Carcinogenicity of dimethylarsinic acid in rats and mice
19. Arsenic-induced DNA-strand breaks associated with DNA-protein crosslinks in human fetal lung fibroblasts
20. DNA strand breaks in mammalian tissues induced by methylarsenics
21. Toxicological profile for arsenic
22. Effects of dietary dimethylarsinic acid on the urine and urothelium of rats
23. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: Association with activating protein-1 transactivation
24. Mutagenicity of arsenic in mammalian cells: Role of reactive oxygen species
25. The role of 8-hydroxyguanine in carcinogenesis
26. Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine
27. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder
28. Increased expression of cyclooxygenase-2 protein in rat lung tumors induced by N-nitrosobis(2-hydroxypropyl)amine
29. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2
30. Antioxidant and redox regulation of gene transcription
31. Microsatellite instability in bladder cancer
32. Genomic instability in neoplasia
33. Molecular detection of primary bladder cancer by microsatellite analysis
34. Urinary excretion of arsenic metabolites after long-term oral administration of various arsenic compounds to rats
35. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features
36. High frequency of beta-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat
37. A genetic linkage map of the laboratory rat, Rattus norvegicus
38. Microsatellite instability and loss of heterozygosity on chromosome 10 in rat mammary tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
39. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation
40. Induction of gene amplification by arsenic
41. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
42. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
43. DNA oxidation matters: The HPLC-electrochemical detection assay of 8-oxo-deoxyguanosine and 8-oxoguanine
44. 8-hydroxy-deoxyguanosine and 8-hydroxyguanosine as biomarkers of oxidative DNA damage
45. Tumor Incidences in Fischer 344 Rats: NTP Historical Data
46. Identification of p53 gene mutations in bladder cancers and urine samples
47. p53 mutations in human cancers
48. p53 mutations in transitional cell carcinomas of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine
49. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan
50. Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan
51. Urothelial cytotoxicity and regeneration induced by dimethylarsinic acid in rats
52. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
53. Cancer prognostics: Past, present and p27
54. Role of cytochromes P-450 in mouse liver tumor production
55. The role of oxidative stress in chemical carcinogenesis
56. Promoting effects of monomethylarsonic acid, dimethylarsinic acid and trimethylarsine oxide on induction of rat liver preneoplastic glutathione S-transferase placental form positive foci: A possible reactive oxygen species mechanism
57. An overview of the relationship between oxidative stress and chemical carcinogenesis
58. Mechanisms involved in the generation of free radicals
59. Dimethylated arsenics induce DNA strand breaks in lung via the production of active oxygen in mice
60. Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical
61. Chemical determination of free radical-induced damage to DNA
62. Increased oxidative stress with gene alteration in urinary bladder urothelium after the Chernobyl accident
63. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1
64. Signal transduction: The nuclear target
65. DNA-strand breaks induced by dimethylarsinic acid, a metabolite of inorganic arsenics, are strongly enhanced by superoxide anion radicals
66. Tumor suppressor genes
67. The molecular genetics of cancer
68. Free radicals in promotion: A chemical pathology study section workshop
69. Enhanced malignant progression of mouse skin tumors by the free-radical generator benzoyl peroxide
70. Overview of tumor promotion in animals